ABN AMRO 4000% until 01/16/2028 (XS2575971994) Noticias

Monksdream, CTAS had a sizable drop on Monday, but no news or filings that I've seen. Earnings is this week, so maybe a miss expected on rev / earnings guidance (?)



Customized 1958 Thunderbird -


https://cdn.dealeraccelerate.com/smt/1/584/1021

LOVE WHEN THE MAGGOTS FOLLOW MY PLAYS AND PRETEND THEY FOUND THEM...THATS WHAT MAGGOTS DO!

I stated my thoughts on the journal article. Note that authorship is not endorsement of a potential commercial product. Those authors simply made a meaningful contribution to the conduct of the trial and readout of its results. Also, adding more authors does not make a paper more (or less) convincin

Elon and Donald will make shiba great again.
Maybe more great then one can imagine.
This may will once as greater than the greatest Greats

Once Spaxe buys out Spandex Tesla will double in share price.

Please see my page and follow my financial advice along with other useless information in section 93-ZQ5.C

Yaba Daba Doo

I guess I feel Your points are not worth responding to..They have been regurgitated by you and friends Ad Nauseum...and responded to..so beside posting here or there I am content for the curtain to be drawn down on the shorts and many friends here to be vindicated (and see much wealth creation for a

China creates mini nuclear battery that can last 50 years without recharging https://x.com/historyinmemes/status/1751958371627065577

lol

Such biomarker support helps. Important to keep in mind though that the biases inherent in an OLE put a hard limit on the reliability of results ("hard conclusions" as you wrote).

Shaping up to be a good week after all that strong consolidation. 

FCEL, 10Q due 12/19 per Seeking Alpha weekend report
https://investorshub.advfn.com/uimage/uploads/2024/12/15/iwkmcIMG_3958.gif

That's correct about survivorship bias. It's one of the bigger potential biases in a long-term uncontrolled study (lack of placebo and blindings is the other). These biases are the reason OLEs are not a primary basis for drug approval.

What I don't get is.....


https://investorshub.advfn.com/uimage/uploads/2024/12/15/blpvkbtc_121212_15_15d_1133am_data_glitch_NH.jpg



I also have sorta been lookin' at this (figure out what interest rates are gonna do and ya' MIGHT ALSO be able to

AVXL, 10Q due 12/19 per Seeking Alpha weekend report
https://investorshub.advfn.com/uimage/uploads/2024/12/15/lk[wyIMG_3957.gif

The dilutive power of TOXIC LOANS:

Toxic lender Robert Papiri holds a loan of $98,233 convertible at the fixed price of $0.0002/share. And the principal amount is rising daily…

Once converted, this will add 491,175,000 new shares to the market

No wonder J

The irony is very thick here. The same folks who riducule others as "ignorant" , "not acknoweldging reality" , "refusing to listen to others" -- will never read that release by FINRA. It's too long of a read for them and/or conflicts with their confirmation bias. I have some beachfront property in

Happy Holidays

Same to you and your family FOFreddie!!

Nats

Werd 🤘

These prices are a gift.

Sharp shells will rocket in 2025 🚀

Graber issued incentives to him and his business buddies for doing nothing. Also, getting salary with co-ceo $400k+ annually...
Scammy scammy

IPX, 10Q due 12/19 per Seeking Alpha weekend report
https://investorshub.advfn.com/uimage/uploads/2024/12/15/cngxxIMG_3956.gif

No need... Old accountant didn't want to cooperate with fraud so they had no choice....
The new accountant ( over a year now ) needs something to work with?? Working with the disclosure is perfect for a "SETUP"
Cart before the horse! Maybe in a few more years if not revolked 

Appreciate your take on this and interested in others commenting. But I don't read it that way.  To me they are indicating that more work is needed to validate EMF as a cardiovascular risk factor for CVD, and possibly explain a MOA for EPA, but in no way are they dissing R-I results.  No question th

I agree with your assessment